New Insight in the Assessment of Left Ventricular Function in Paradoxical Low Flow Aortic Stenosis Patients with Normal Left Ventricular Ejection Fraction: A Mini-Review ()
1. Introduction
The most challenging finding in clinical practice is associated with paradoxical severe valvular aortic stenosis (VAS). It is an aortic valve area (AVA) of <1 cm2 with a peak velocity of <4 m/s and a mean pressure gradient of <40 mm Hg despite normal LVEF. Subclinical myocardial dysfunction that is characterized by impaired left ventricular (LV) global longitudinal systolic strain (GLS) is often present in patients with a symptomatic severe AS with preserved LVEF. This is due to LVEF which is highly dependent on preload and afterload and its depression seems to occur at a very late stage in many valvular-induced heart diseases.
2. Application of Deformation Imaging and Myocardial Performance in Clinical Practice
The entity of “paradoxical” low flow and low gradient AS with preserved LVEF refers to patients with hypertrophied, small ventricles resulting in reduced trans-valvular flow for which stroke volume index (SVi) of <35 mL/m2 is a surrogate despite normal LVEF [1]. However, this entity has to be diagnosed with particular care as there may be other small valve area and low gradient in the presence of normal LVEF. This may be more likely to occur during technical factors in AVA calculation ((error in measurements of left ventricular outflow (LVOT) diameter)) and as such they have to be carefully excluded. So, the main pitfalls associated with conventional transthoracic echocardiographic diagnosis of paradoxical low flow low gradient AV stenosis are an error in calculation of the SV due to inaccurate measurements of LVOT diameter (TTE tends to underestimate the diameter of LVOT partly due to elliptical rather than circular anatomy and in the presence of extensive calcification) and/or misplacement (misalignment) of pulsed-wave Doppler sample volume (too low in the LVOT or too lateral towards the anterior mitral valve leaflet may lead to underestimation of flow velocity and thus low SV, whereas a position too close to the valve or to the septum may lead to overestimation) [1]. This mini review has relevant clinical application: in the assessment of left ventricular function. Severe “paradoxical” low flow low gradient AS with preserved LVEF has in commonly more prevalent in patients of older age, in women, and in patients with concomitant system arterial hypertension (HTN) [1]. Reduced longitudinal LV function and fibrosis have been found in many cases (see Figure 1). However, the vast majority of these patients had a history of HTN that may also have caused the LV remodeling (hypertrophy and fibrosis) [1] [2]. Furthermore, uncontrolled arterial hypertension can affect the flow and pressure gradient values in severe aortic valve stenosis. This entity is most frequently characterized by restrictive physiology in relation to more pronounced LV concentric remodeling, reduced, LV cavity size, impaired LV filling, and reduced systemic arterial compliance [3]. Accordingly, diastolic dysfunction and filling pressure (left atrial/left ventricular end diastolic pressure. (LVEDP)) should be initially assessed non-invasively by conventional mitral Doppler flow, tissue Doppler imaging (TDI), left atrial pressure (E/Ea), and pulmonary venous flow as illustrated in Figure 1.
Alternative to LVEF, the following techniques are able to assess LV myocardial function accurately in low flow AS patients with normal EF and they include:
1) Mitral annular displacement by TDI < 12 mm;
2) Global longitudinal strain of the LV (GLS) by 2D STE (see Figure 1 & Figure 2) [4];
3) Myocardial Performance index (Tei Index) > 0.42. 58 - 63 (see Figure 3; [5] - [10] );
4) BNP levels > 550 pg/ml [11] and;
5) Maximum rate of LV pressure development (see Figure 4) [12].
3. Left Ventricular Global Longitudinal Strain (LV GLS)
A recent meta-analysis study [13] demonstrates that in asymptomatic patients with significant AS and normal LVEF, impaired (LV) GLS is associated with reduced survival time. These data emphasize the potential usefulness of LV GLS for risk stratification and management of these patients (see Figure 2) [13]. This meta-analysis included 10 studies, 1067 asymptomatic patients with significant AS and LVEF > 50% were analyzed. The median of left ventricular (LV) GLS was
(a)
(b)
(c)
Figure 1. This figure illustrates the role of global longitudinal systolic strain (GLS) in the diagnosis of subclinical systolic dysfunction-and normal LVEF in arterial hypertension. (a) shows 2D Strain for detection of subclinical LV dysfunction and normal EF (GLPSS-13%), in hypertensive patient with low GLS in AS patient with paradoxical low flow-low gradient severe AS. (b) shows grade III/IV diastolic dysfunction by conventional Doppler flow and (c) shows evidence of diastolic dysfunction by tissue Doppler imaging (Ea < 5 cm/s).
![]()
Figure 2. Global LONGITUDINAL Strain by 2D speckle tracking echocardiography showing depressed GLS (−12.4%) in the presence of normal LVEF (56.2%) in paradoxical low flow AS (taken from reference [14] ).
![]()
Figure 3. Schematic diagram showing how to measure index of myocardial performance (MPI): isovolumetric relaxation time (IVRT), isovolumetric contraction time (IVCT), LV ejection time (LVET), MPI = IVRT + IVCT/LVET.
(a)
(b)
Figure 4. (a) 4 chambers 2D echocardiography showing moderate mitral valve incompetence in a patient with AS but normal ejection fraction (EF = 51%). (b) shows that maximum rate of LV positive pressure development (+dP/dt) which is depressed in the same patient (645 mm Hg) and with measurement of dP/dt at 1st and 3rd m/seconds of mitral regurgitation (MR) continuous wave Doppler (CWD) slope (taken from reference [12] ).
−16.2% (from −5.6% to −30.1%). There were 91 deaths reported during follow-up with median of 1.8 (0.9 to 2.8) years, resulting in a pooled crude mortality rate of 8.5%. The LV GLS performed well in the prediction of death (area under the curve: 0.68). The best cut off value identified was LV GLS of −14.7% (sensitivity, 60%; specificity, 70%). Using random effects model, the risk of death for patients with LV GLS < −14.7% (p < 0.0001), without significant heterogeneity between studies (I2 = 18.3%; p = 0.275). The relationship between LV GLS and mortality remained significant in patients with LVEF ≥ 60% (p = 0.001). Similarly, Lancellotti et al. [11] examined a cohort of 163 patients with at least moderate to severe, asymptomatic AS. They demonstrated that impaired LV longitudinal myocardial deformation was an independent predictor of survival. Those patients with longitudinal strain > −15.9% had significantly better outcome than patients with the strain below −15.9% (4-year survival of 63 vs. 22, p < 0.001).
Interestingly, Elkilany et al. [14] found a concomitant dilated cardiomyopathy which was observed in 1.8% of subjects with bicuspid aortic valve (BAV). A few different clinical and echocardiographic characteristics were found. They concluded that, the presence of cardiomyopathy was independently associated with heart failure either clinically or at the sub clinical stage, which can be identified by global systolic strain.
4. Myocardial Performance Index (MPI)
The Doppler-derived myocardial performance index (MPI) has been considered as a diagnostic and prognostic Doppler marker for many different clinical conditions. TDI-MPI and PWD-MPI were significantly higher in patients with grade I diastolic dysfunction (DDI) than in control subjects: 0.49 ± 0.14 vs. 0.40 ± 0.09 (p < 0.001) and 0.45 ± 0.11 vs. 0.37 ± 0.08 (p < 0.001), respectively. Cutoff values of TDI-MPI > 0.42 and PWD-MPI > 0.40 identified DDI subjects, with sensitivities of 74% and 64%; specificities of 61% and 69% [5].
Initial diastolic dysfunction detected by Doppler echocardiography is an independent risk factor for the development of heart failure and all-cause mortality, even in asymptomatic patients [6]. The myocardial performance index (MPI) or Tei-Index, described more than a decade ago, has been well documented in the literature as a prognostic and progression marker for various heart diseases [6] [7] [8]. However, in the majority of these studies, MPI was used in patients with combined systolic and diastolic dysfunctions. One limitation of the conventional Doppler-derived Myocardial Performance Index (PWD-MPI) method is that the measures of time intervals which are based on flow-velocity curves and are performed in different cardiac cycles. This method requires several measurements to reduce beat-to-beat variation. An alternative for MPI calculation is the use of the pulsed-wave tissue Doppler imaging-derived myocardial performance index (TDI-MPI), which allows simultaneous measurement of both the diastolic and systolic intervals in the same cardiac cycle, with high diagnostic accuracy in subjects with heart failure and left-ventricular dysfunction [9] [10].
5. Dobutamine Stress Echocardiography (DSE)
Low dose DSE may be used to rule-out pseudo-severe AS, but may not be applicable or conclusive in a significant proportion of patients with paradoxical low
(a)
(b)
Figure 5. 3D echocardiography (a) during DSE (b) is feasible in the majority of pts with severe low flow low gradient AS to identify pseudo low flow but severe critical AS, 3DE is able to estimate accurately the LVEF and SV index at rest and during peak stress.
flow low gradient AS, particularly in those patients with Doppler evidence of restrictive LV physiology (restrictive filling pattern) (Figure 5) [15] [16].
In conclusion, the implication of cardiac ultrasound with routine use of GLS via 2D STE is a gold standard for the early detection and proper management of cardiac dysfunction in a symptomatic severe AS patients and this is reasonably recommended in BAV patients. In addition, an accurate assessment of LV contractility is feasible by MPI and maximum rate of LV pressure development. The depression of these parameter values is considered an independent risk factor for the development of heart failure and all-cause mortality, even in asymptomatic patients and the need for early intervention (aortic valve replacement).